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Abstract
Background: Although the positive relationship between insulin resistance (IR) and central obesity is well known,
the direct relationship between waist circumference and IR is not clear yet and there is no consensus regarding
the cut off value for waist circumference as a surrogate index for central obesity. The present study was aimed to
determine the optimal cut-off value of waist circumference (WC) for predicting IR in reproductive aged Iranian
women.
Methods: Using the stratified, multistage probability cluster sampling method 1036 women were randomly
selected from among reproductive aged women of different geographic regions of Iran. Following implementation
of exclusion criteria, complete data for 907 women remained for analysis. Insulin resistance was evaluated by the
homeostasis model assessment (HOMA-IR) and its cut off value was defined as the 95th percentile of HOMA-IR
value for 129 subjects, without any metabolic abnormality. The optimal cut-off of WC in relation to HOMA-IR was
calculated based on the receiver operating characteristics (ROC) curve analysis using the Youden index and the
area under curve (AUC).
Results: The mean age of the total sample of 907 subjects was 34.4 ± 7.6 years (range, 18 - 45 years). After
adjustment for age the odds ratios (OR) of elevated HOMA-IR were progressively higher with increasing levels of
waist circumference; the age adjusted OR of IR for women with WC > 95 cm in comparison to those subjects with
WC < 80 cm, was 9.5 (95% CI 5.6-16.1). The optimal cutoff value for WC predicting IR was 88.5 cm; with a
sensitivity and specificity of 71% and 64%, respectively.
Conclusions: Waist circumference is directly related to insulin resistance and the optimal cut-off value for waist
circumference reflecting insulin resistance is considered to be 88.5 cm for reproductive aged Iranian women.
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Background
Insulin resistance (IR) is the main pathophysiological
feature of the metabolic syndrome (MetS), which in
turn leads to increased risk of cardiovascular disease
[1,2]. Central obesity, main diagnostic criteria for the
MetS, is considered to predispose individuals for insulin
resistance [3-5]. Waist circumference (WC); the best
anthropometric indicator of central obesity [6,7], is clo-
sely associated with IR and provides a rapid, inexpensive
and non-invasive way of identifying the presence of IR
[8-11].
The International Diabetes Federation (IDF) has
declared that waist is a gender and ethnic-group specific
indicator and has adopted different cut-offs for waist cir-
cumference in different ethnicities [12,13]. The cut-off
points for Euripides are 94 cm in men and 80 cm in
women, while those for Chinese and South Asians are 90
cm in men and 80 cm in women [12]. For Iranians, based
on both cross-sectional and longitudinal outcome based
studies, the cut-off point of 95 cm for WC to diagnose
MetS was identical in men and women [14,15]. However,
these studies were primarily based on the relationship
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vascular disease or multiple components of the metabolic
syndrome other than insulin resistance [15-17] and there
are a limited population-based studies for defining cut-
off values of WC for diagnosis of IR [18-20]. Considering
the lack of population based and sex specific data regard-
ing optimal WC cut-off point for predicting IR in
Iranians, we aimed to clarify the optimal cut-off point for
diagnosis of insulin resistance, determined by homeosta-
sis model assessment of insulin resistance (HOMA-IR),




This cross sectional study was conducted in four ran-
domly selected provinces of different geographic regions
of Iran, i.e. Ghazvin (Central), Kermanshah (East), Gole-
stan (North) and Hormozgan (South). A total of 1036
women, aged 18-45 years were selected using a stratified,
multistage probability cluster sampling method. The
frame for the selection of the sampling units was based
on the Iranian household lists available in the Health
Department. Menopausal women, those who had under-
gone hysterectomy or bilateral oophorectomy and preg-
nant women were excluded. A checklist questionnaire
was completed at subjects’ homes and eligible women
were invited to a referral clinic in each province for a
comprehensive interview and physical exam. Ultimately,
data for 907 subjects remained in the final analysis that
had completed questionnaire, physical and clinical
exams.
Weight (kg) was measured while the patient was dressed
in light clothing and without shoes, using digital scales
and was recorded to the nearest 0.5 kg. Height was mea-
sured in a standing position, without shoes, using a mea-
suring tape, while the shoulders were in a normal position
and was recorded to the nearest 0.5 cm. Blood pressure
was measured by a standard mercury sphygmomanometer
with an appropriate sized cuff for arm diameter after
5 minutes rest and checked twice at an interval of at least
5 min. The mean value of these two measurements was
used for the analyses. Waist was measured midway
between the lower rib margin and the iliac-crest at the
end of a gentle expiration. Body mass index was calculated
as weight in kilograms divided by the height in meters
squared (kg/m
2).
An overnight fasting venous blood sample was obtained
from each participant. Blood samples were collected in
EDTA-treated test tubes. Plasma was separated in a refri-
gerated centrifuge at 3000 rpm for ten minutes. The sera
were stored at -80°C until tested. Fasting serum glucose,
triglycerides (TG), total cholesterol (TC) and high-density
lipoprotein cholesterol (HDL-C) were measured using the
enzymatic colorimetric method (Pars Azmon Inc., Tehran,
Iran) by a Selectra 2 auto-analyzer (Vital Scientific,
Spankeren, The Netherlands). The Friedewald equation
was used to calculate low-density lipoprotein cholesterol
(LDL- C); samples with TG greater than 400 mg/dl were
assayed by a direct method. In all of these biochemical
analyses, the inter- and intra-assay coefficients of varia-
tions were less than 2.5% and 3.2%, respectively. Insulin
was assessed by the Immuno Enzyme Metric Assay
(IEMA) (Mercodia, Uppsala, Sweden) and its intra- and
inter-assay coefficients of variation were 2.4% and 5.8%,
respectively. The ethical review board of the Research
Institute for Endocrine Sciences approved the study pro-
posal and informed consent was obtained from all
subjects.
Definitions
Insulin resistance was estimated by HOMA-IR according to
the formula
HOMA-IR = [(Fasting serum insulin (μU⁄ L) × Fasting
plasma glucose (mmol ⁄ L)] 22.5. Of the 907 subjects, insu-
lin resistance cut-off value was 2.63 as determined using
the 95th percentile of HOMA-IR of 129 study participants
with BMI < 25 kg/m, non-diabetic (FBS < 126 mg/dl) and
non-hypertensive (systolic blood pressure ≤ 130 mmHg,
diastolic blood pressure ≤ 85 mmHg).
Statistical analysis
Continuous variables were checked for normality using
the one-sample Kolmogorov-Smirnoff test, and are
expressed as mean ± standard deviation and/or median
and interquartile ranges, as appropriate. The categorical
variables are expressed as percentages. To assess the abil-
ity of WC to discriminate between women who were
insulin resistant and those were not, receiver operating
characteristics curve (ROC) was constructed and the area
under the curve (AUC) was calculated. Using coordinates
for drawing the ROC curve, the cut-off point for WC
that had optimal values for sensitivity and specificity was
calculated. We identified the optimal values for sensitivity
and specificity as the ones that keep (1 - sensitivity)
2 +
(1 - specificity)
2 at minimum [21]. Data were analyzed
using SPSS 15 statistical software (SPSS Inc., Chicago,
IL).
Results
Table 1 describes the characteristics of the study sub-
jects. Age ranged between18-45 years, with a mean of
34.2 and body mass index (BMI) ranged between12.5-
53.5 kg/m
2 with a mean of 26.9. Using the cut-off value
2.63 for identifying women with insulin resistant, there
was 192 (21.2%) subjects categorized as the IR group.
The characteristics and cardiovascular risks of women,
with and without IR are demonstrated in Table 2. All of
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significantly higher among women with insulin resis-
tance. The relationship between WC and HOMA-IR
index is shown in Figure 1. There was a significant posi-
tive correlation between WC and HOMA-IR index (r =
0.32, p < 0.001).
The odds ratios (ORs) for having IR were increased
according to WC categories. The age adjusted OR for
having IR for women with WC > 95 cm in comparison
to those subjects with WC < 80 cm, were 9.5 (95% CI
5.6-16.1) (Table 3).
Figure 2 presents the ROC curves for the ability of the
waist circumference to identify women with insulin resis-
tance. Using the ROC curve analysis the optimal value
for sensitivity and specificity that keep (1 - sensitivity)
2 +
(1 - specificity)
2 at minimum was 88.5 cm. Sensitivity
and specificity were 71% and 64%, respectively.
Discussion
In this population based cross sectional study we
found that 88.5 cm is the optimal cut-off for predicting
IR for reproductive aged Iranian women, our results
indicating a significant, linear relationship between
waist circumference and insulin resistance, measured
by HOMA-IR. The odds ratio for the risk of insulin
resistance using a cut-off < 80 cm for WC as a refer-
ence, increased progressively in proportion to the size
of waist circumference.
Since insulin resistance is considered as an independent
predictor for age related diseases, including cardiovascular
disease, access to an accurate tool for measurement of the
IR plays a vital role [22,23]. Although the euglycemic
hyperinsulinemic clamp (Clamp-IR) is considered as the
gold standard technique for estimation of insulin resis-
tance, it is not applicable in epidemiologic studies.
HOMA-IR, which is calculated from fasting plasma glu-
cose (FPG) and insulin (FIRI), is highly correlated with the
Clamp-IR; therefore it is a useful surrogate index of insulin
resistance in both healthy and diabetic subjects [24-26].
Despite the wide use of HOMA-IR, no consensus has
been reached regarding the HOMA-IR cut-off value for
identifying subjects with IR. Lee et al. [27] and Radikova
et al. [28] selected the 75
th percentile of non-diabetic
population for cut-off point of IR which corresponded
with HOMA-IR values of 3.04 and 2.29 respectively. How-
ever, Ascaso et al defined insulin resistance as a HOMA
index > 3.8, corresponding to the 90th percentile of the
distribution in a healthy adult Spanish population [29].
The threshold values of HOMA-IR to determine IR, in an
Iranian population (aged 20-77 years), using the lower
limit of the top quintile of HOMA-IR distribution values
in normal subjects, was defined as 1.78 (1.69 for men and
1.81 for women); additionally, racial and ethnic variability
in the HOMA-IR cut points to diagnose IR is probable
[30,31]. Therefore, to implement the HOMA-IR method
successfully, it is important to define specific cut-points
for the race or age of the studied population. In the pre-
sent study, a HOMA-IR value of 2.63, which corresponds
to the 95th percentile of a population of healthy Iranian
women, was chosen arbitrarily to define IR and to examine
its relationship with WC. The prevalence of IR estimated
in our study population was 21%, which is lower than that
reported by Esteghamati (41.5%) [31], and can be
explained by including younger and pre menopausal
women in our study.
Table 1 Characteristics of the study subjects (n = 907)
Variable Value
(means ± SD)
Age (Year) 34.4 ± 7.6
Systolic blood pressure (mmHg) 109 ± 14
Diastolic blood pressure (mmHg) 69.2 ± 11
Total cholesterol (mg/dl) 185 ± 42
LDL cholesterol (mg/dl) 111 ± 35
HDL cholesterol (mg/dl) 45 ± 13
Triglycerides (mg/dl) 142 ± 98
Weight (kg) 67.5 ± 12.8
Height (m) 159 ± 6
BMI (kg/m
2) 26.9 ± 5.1
Waist (cm) 85.0 ± 12.2
Hip (cm) 105 ± 11
Fasting plasma glucose (mg/dl) 88.9 ± 26.1
Fasting plasma insulin (UI/ml) 9.0 ± 9.1
HOMA 2.1 ± 2.8
Insulin resistance(%) 21.2*
*Percent of women with insulin resistance.
Table 2 Characteristics of the study subjects according to
the IR status (measured in terms of the HOMA value)
With IR Without IR P-value
(n = 192) (n = 715)
Age (Year) 34.9 ± 7.4 34.2 ± 7.7 0.256
Glucose (mg/dL) 106 ± 39 84.2 ± 18.2 < 0.001
Insulin (UI/mL) 19.1 ± 15.5 6.3 ± 2.7 < 0.001
HOMA 5.1 ± 5.1 1.29 ± 0.6 < 0.001
Total cholesterol (mg/dL) 200 ± 47 180 ± 39 < 0.001
LDL cholesterol (mg/dL) 120 ± 41 109 ± 33 < 0.001
HDL cholesterol (mg/dL) 39.5 ± 14.2 46.5 ± 12.2 < 0.001
Triglycerides (mg/dL) 201 ± 150 126 ± 70 < 0.001
Weight (kg) 74.4 ± 13.7 65.5 ± 11.8 < 0.001
Height (m) 158 ± 5 159 ± 6 0.799
BMI (kg/m2) 29.7 ± 5.6 26.1 ± 4.6 < 0.001
Waist (cm) 91.7 ± 12 83.1 ± 11.6 < 0.001
Hip (cm) 110 ± 12 103 ± 11 < 0.001
Systolic blood pressure (mmHg) 111 ± 14 108 ± 14 0.002
Diastolic blood pressure (mmHg) 70.4 ± 11.4 68.9 ± 10.9 0.087
Values are means ± SD.
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waist circumference as a surrogate index for central obe-
sity or as a component of metabolic syndrome, and this
value is influenced by several factors including race, age,
life style and reproductive status [13,32]. Several studies
designed to determine the WC cut off values for diagnos-
ing MetS in Iranian populations suggested a greater value
in comparison to western populations [15-17], a higher
value which may be explained by ethnic differences in
body fat distribution, sedentary lifestyles and high carbo-
hydrate diets and also the genetic tendency of Iranians to
central obesity [33,34]. Nevertheless, there was no con-
sensus regarding their suggested cut off value, which is
influenced by the type of study or subject selection. The
f i r s tn a t i o n a ls u r v e yi na nI ranian population of 3,024
adults revealed that the WC cut-offs for predicting at
least two other components of the IDF-defined metabolic
syndrome were 89 cm for men and 91 cm for women
[15] while an outcome based cohort study suggested a
WC cut-off of 94.5 [16]. Recently the Iranian National
Committee of Obesity announced equal waist circumfer-
ence cut-offs of ≥ 90 cm in both genders at risk for CVD
risk factors, and that of ≥ 95 cm in both genders to be at
high risk CVD events requiring immediate preventive
measures [14].
The present study demonstrated that 88.5 cm is the
optimal cut off for predicting IR for reproductive aged
Iranian women, a value which was not changed consid-
ering the HOMA-IR values corresponding to the 90 and
≥ 97.5th percentile (2.31 and 3.65 respectively). Our
proposed WC cutoff value is lower than those of the
aforementioned studies for Iranian women. Considering
the critical influence of aging on body fat distribution
[35-38] this lower cut-off value may be explained by the
fact that our study population is young, not yet influ-
enced by menopausal status.
The main strength of the present study is its metho-
dology, as it is a community based prevalence study car-
ried out on an ethnically homogenous population, with
an appropriate response rate of 90%. The amount of
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Figure 1 Title Scatter plot of the relation between WC and HOMA-IR index in women. The vertical line indicates the optimal WC cut-off
point, derived from the ROC curve, for predicting IR (88.5 cm). The horizontal line delineates cases with IR (HOMA-IR ≥ 2.63).
Table 3 Age-adjusted odds ratios of elevated HOMA-IR according to categories of waist circumference
Number of women (%) Odds ratio (95% confidence interval)
Waist (cm) Total Elevated HOMA-IR* Age-adjusted
< 80 344 31(9%) 1.0 (referent)
80-84 129 25(19.4%) 2.3 (1.3-3.9)
85-89 150 35(23.3%) 2.6 (1.6-4.2)
90-94 102 25(24.5%) 3.4 (2-5.8)
95 ≤ 182 76(41.8%) 9.5 (5.6-16.1)
* The HOMA-IR ≥ 95% percentile (≥ 2.63)
Zadeh-Vakili et al. Diabetology & Metabolic Syndrome 2011, 3:18
http://www.dmsjournal.com/content/3/1/18
Page 4 of 6intra-assay variability in our data is also likely to be
minimal because all the laboratory measurements were
d o n ea tt h es a m el a b o r a t o r yb yt h es a m ep e r s o n .T h e
educational status and the prevalence of obesity in the
present study was the same as that reported in a
national study [39] and hence could justify and confirm
our population as being representative of reproductive
aged Iranian women. However as a main limitation we
did not use gold standard technique for assessment of
insulin resistance.
Conclusions
In conclusion, our results revealed that 88.5 cm is the
optimal cut off proposed for predicting IR for Iranian
reproductive aged women. A comprehensive study for
evaluation of the correlation between the values of
HOMA-IR and Clamp-IR among reproductive aged
women is suggested.
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